Keywords: ایمونوتوکسین ها; Interleukin-4; Allergic asthma; Cancers; Antagonistic antibodies; Immunotoxins; IL-4 mutant analogs;
مقالات ISI ایمونوتوکسین ها (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمونوتوکسین ها; Antibodies; Immunoconjugates; Immunotoxins; Ab; antibody; Ag; antigen; ADCC; antibody-dependent cell mediated cytotoxicity; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; AKT; protein kinase B; APC; antigen-presenting cell; Apo2L/TRAIL; t
Keywords: ایمونوتوکسین ها; Ribosome-inactivating proteins; Immunotoxins; Antiviral; Antifungal; Insecticidal activity; Resistance to stress;
HER2-targeted immunotoxins with low nonspecific toxicity and immunogenicity
Keywords: ایمونوتوکسین ها; HER2-target; Immunotoxins; Nonspecific toxicity; Immunogenicity;
Research paperStructural constraints-based evaluation of immunogenic avirulent toxins from Clostridium botulinum C2 and C3 toxins as subunit vaccines
Keywords: ایمونوتوکسین ها; Point mutation; Fold rate; Molecular dynamic simulation; ADP-ribosyltransferase; Virulence; Clostridium botulinum; Immunotoxins; C3 toxin; Molecular docking; Structural evolution; C2 toxin;
Comparative label-free monitoring of immunotoxin efficacy in 2D and 3D mamma carcinoma in vitro models by impedance spectroscopy
Keywords: ایمونوتوکسین ها; Impedance spectroscopy; 3D tumor model; Immunotoxins; Microcavity array; Interdigital electrode array
A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin
Keywords: ایمونوتوکسین ها; immunotoxins; carcinoma in situ; urinary bladder; administration; intravesical; clinical trials; phase IIAE, adverse event; BCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; CR, complete response; EOS, end of study; EpCAM, epithelial cell adhesion mo
Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer
Keywords: ایمونوتوکسین ها; Hybrid peptide; Immunotoxins; Drug targeting; Neurophilin-1; Sema 3A;
Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment
Keywords: ایمونوتوکسین ها; Hairy-cell leukemia variant; Japanese variant; Molecular biology; Purine nucleoside analogs; Rituximab; Immunotoxins
A novel hybrid peptide targeting EGFR-expressing cancers
Keywords: ایمونوتوکسین ها; Drug resistance; Drug targeting; EGFR; Hybrid peptide; Immunotoxins
Modified DT–IL2 fusion toxin targeting uniquely IL2Rα expressing leukemia cell lines – Construction and characterization
Keywords: ایمونوتوکسین ها; Diphtheria toxin; Interleukin-2; Interleukin-2 receptor; Immunotoxins; Fusion toxins
Emerging immunotherapies targeting CD30 in Hodgkin's lymphoma
Keywords: ایمونوتوکسین ها; Cancer; Tumor necrosis factor (TNF); Hodgkin's lymphoma (HL); Anaplastic large cell lymphomas (ALCL); Hematologic malignancies; Lymphoproliferative diseases; Reed–Sternberg cells; Antibody–drug conjugates; Immunotoxins; Immune evasion
Current treatment concepts for neuromas-in-continuity
Keywords: ایمونوتوکسین ها; Neuroma-in-continuity; Suicide transport; Immunolesioning; Immunotoxins; OX7; Saporin
Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy
Keywords: ایمونوتوکسین ها; Nanoparticles; PLGA; Immunotoxins; Targeted delivery; rhuMAbHER2
Recombinant antibodies with T-cell receptor-like specificity: Novel tools to study MHC class I presentation
Keywords: ایمونوتوکسین ها; Antibodies; MHC-peptide complex; T-cell receptor; Recombinant antibodies; Cancer immunotherapy; Phage display; Antibody engineering; Immunotoxins
Monoclonal antibodies in the treatment of lung cancer
Keywords: ایمونوتوکسین ها; Lung cancer; Monoclonal antibodies; Anti-idiotype vaccines; Immunotoxins; (Radio)Immunoconjugates; Prodrug activation; T cell activation; Intrabodies; T bodies; Radioimmunoguided surgery; Immunoguided focal ablation
Cancer therapy with engineered monoclonal antibodies
Keywords: ایمونوتوکسین ها; Monoclonal antibodies; ADCC; Immunotoxins; Conjugated antibodies; Fc receptors; Phage display; Bispecific antibodies; Single chains; Herceptin; Cetuximab; Rituximab
Current treatment options in hairy cell leukemia and hairy cell leukemia variant
Keywords: ایمونوتوکسین ها; Hairy cell leukemia; Variant form; Purine nucleoside analogs; Cladribine; Pentostatin; Interferon α; Rituximab; BL22; Immunotoxins; Splenectomy
Multiple myeloma: Monoclonal antibodies-based immunotherapeutic strategies and targeted radiotherapy
Keywords: ایمونوتوکسین ها; Multiple myeloma; Haematologic malignancies; Bone marrow microenvironment; MoAbs; Immunoconjugates; Immunotoxins; Targeted radioimmunotherapy; Skeletal targeted radiotherapy
Tailor-made antibody therapeutics
Keywords: ایمونوتوکسین ها; Therapeutic antibodies; Antibody engineering; Affinity maturation; Effector functions; FcRn binding; Antibody fragments; Immunoconjugates; Immunotoxins; Immunocytokines; ADEPT; Radio-labeled antibodies; Bi-specific antibodies; PEGylation;